How I treat a refractory myeloma patient who is not eligible for a clinical trial

Myeloma patients not eligible for clinical trials have many treatment options. Choosing the next best therapy starts with careful assessment of the biology and dynamics of the disease at relapse, as well as the condition and situation of the patient. Fit patients should be considered for triplet reg...

Full description

Saved in:
Bibliographic Details
Published in:Hematology Am Soc Hematol Educ Program
Main Authors: Leng, Siyang, Bhutani, Divaya, Lentzsch, Suzanne
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2019
Subjects:
Challenges in Myeloma Therapy
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913488/
https://ncbi.nlm.nih.gov/pubmed/31808850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000016
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items